ā­ļøā­ļøā­ļøā­ļøā­ļø "A total no brainer"

ā­ļøā­ļøā­ļøā­ļøā­ļø "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recentin

Every month we try and update this database with for recentin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOXNCT00384176
Colorectal Canc...
Cediranib
Bevacizumab
5-fluorouracil ...
Leucovorin (in ...
Oxaliplatin (in...
18 Years - 130 YearsAstraZeneca
Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid TumoursNCT00264004
Tumors
AZD2171
18 Years - AstraZeneca
Cediranib (AZD2171, RECENTINā„¢) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerNCT00399035
Metastatic Colo...
Cediranib
FOLFOX (5-fluor...
XELOX (Capecita...
Cediranib Place...
18 Years - 130 YearsAstraZeneca
Phase I Safety and Tolerability Study of Cediranib (RECENTINā„¢, AZD2171) in Combination With Chemo in First Line Lung Cancer PatientsNCT00621361
Lung Cancer
AZD2171
Etoposide
Cisplatin
18 Years - AstraZeneca
Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)NCT00278889
Colorectal Canc...
AZD2171
5-fluorouracil
Leucovorin
Oxaliplatin
Bevacizumab
18 Years - AstraZeneca
A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOXNCT00494221
Metastatic Colo...
AZD2171
FOLFOX (5-fluor...
Placebo Cediran...
18 Years - AstraZeneca
Cediranib (AZD2171, RECENTINā„¢) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerNCT00399035
Metastatic Colo...
Cediranib
FOLFOX (5-fluor...
XELOX (Capecita...
Cediranib Place...
18 Years - 130 YearsAstraZeneca
The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck CancerNCT00243347
Carcinoma
Non-Small-Cell ...
Head and Neck N...
AZD2171
18 Years - AstraZeneca
Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX)NCT00278889
Colorectal Canc...
AZD2171
5-fluorouracil
Leucovorin
Oxaliplatin
Bevacizumab
18 Years - AstraZeneca
DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)NCT00748891
Cancer
Recentin (Cedir...
18 Years - AstraZeneca
Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentinā„¢)NCT00306891
Cancer
Cediranib
Cediranib 30 - ...
18 Years - AstraZeneca
Phase I Safety and Tolerability Study of Cediranib (RECENTINā„¢, AZD2171) in Combination With Chemo in First Line Lung Cancer PatientsNCT00621361
Lung Cancer
AZD2171
Etoposide
Cisplatin
18 Years - AstraZeneca
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).NCT00385203
Gastrointestina...
Soft Tissue Sar...
AZD2171
18 Years - AstraZeneca
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: